SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-23-000497
Filing Date
2023-07-24
Accepted
2023-07-24 17:46:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2733
  Complete submission text file 0001972362-23-000497.txt   4278
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Barrett Peter (Reporting) CIK: 0001291895 (see all company filings)

Type: 144

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36510 | Film No.: 231105955
SIC: 2834 Pharmaceutical Preparations